![John Bisi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
John Bisi has held the title of Senior Vice President-Research & Development at Incyclix Bio LLC since 2020.
He is the founder of Incyclix Bio LLC, which was founded in 2020.
Cargos activos de John Bisi
Empresas | Cargo | Inicio |
---|---|---|
Incyclix Bio LLC
![]() Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Fundador | 01/05/2020 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Incyclix Bio LLC
![]() Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- John Bisi